Insider trading

Period: 12 months Stock: LAES + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

38 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

38 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

38 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

38 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
38 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
38 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

38 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
6 Oct 2026
Enguent Jean-Pierre Vice President, R&DSS
Sold on a plan
$85.94K 35,000 at 2.46
100%
Sold half or more
3 Sep 2026
Enguent Jean-Pierre Vice President, R&DSS
Sold on a plan
$36.03K 15,000 at 2.40
100%
Sold half or more
5 Aug 2026
Enguent Jean-Pierre Vice President, R&DSS
Sold on a plan
$36.86K 15,000 at 2.46
100%
Sold half or more
8 Jul 2026
Enguent Jean-Pierre Vice President, R&DSS
Sold on a plan
$42.27K 15,000 at 2.82
100%
Sold half or more
5 Jun 2026
Moreira Carlos Chief Executive Officer
Sold on a plan
$1.05K 300 at 3.51
0.0%
Planned (10b5-1)
5 Jun 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$501.93 143 at 3.51
0.1%
Planned (10b5-1)
3 Jun 2026
Enguent Jean-Pierre Vice President, R&DSS
Sold on a plan
$52.65K 15,000 at 3.51
100%
Sold half or more
3 Jun 2026
Moreira Carlos Chief Executive Officer
Sold on a plan
$24.74K 7,005 at 3.53
1.0%
Planned (10b5-1)
3 Jun 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$19.70K 5,582 at 3.53
2.2%
Planned (10b5-1)
2 Jun 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$36.93K 10,000 at 3.69
3.8%
Planned (10b5-1)
2 Jun 2026
Moreira Carlos Chief Executive Officer
Sold on a plan
$36.91K 10,000 at 3.69
1.4%
Planned (10b5-1)
29 May 2026
Moreira Carlos Chief Executive Officer
Sold on a plan
$35.09K 10,000 at 3.51
1.4%
Planned (10b5-1)
29 May 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$35.08K 10,000 at 3.51
3.6%
Planned (10b5-1)
27 May 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$16.43K 4,689 at 3.50
1.7%
Planned (10b5-1)
27 May 2026
Moreira Carlos Chief Executive Officer
Sold on a plan
$14.50K 4,139 at 3.50
0.6%
Planned (10b5-1)
14 May 2026
Buonanno Franck Jean Vice-President, Global Sales
Sold on a plan
$58.00K 20,000 at 2.90
66.7%
Sold half or more
6 May 2026
Enguent Jean-Pierre Vice President, R&DSS
Sold on a plan
$47.00K 15,000 at 3.13
100%
Sold half or more
24 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$15.26K 5,250 at 2.91
1.8%
Planned (10b5-1)
23 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$28.80K 10,000 at 2.88
3.4%
Planned (10b5-1)
22 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$30.56K 10,000 at 3.06
3.3%
Planned (10b5-1)
21 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$30.38K 10,000 at 3.04
3.2%
Planned (10b5-1)
20 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$27.88K 10,000 at 2.79
3.1%
Planned (10b5-1)
17 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$27.21K 10,000 at 2.72
3.0%
Planned (10b5-1)
16 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$26.95K 10,000 at 2.69
2.9%
Planned (10b5-1)
9 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$20.82K 10,000 at 2.08
4.4%
Planned (10b5-1)
8 Apr 2026
Enguent Jean-Pierre Vice President, R&DSS
Sold on a plan
$32.98K 15,000 at 2.20
100%
Sold half or more
8 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$21.98K 10,000 at 2.20
4.2%
Planned (10b5-1)
7 Apr 2026
Feuardent Moreira Andreas Chief Innovation Officer · indirect
Sold on a plan
$23.10K 10,000 at 2.31
100%
Sold half or more
7 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$21.38K 10,000 at 2.14
4.1%
Planned (10b5-1)
6 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$24.17K 10,000 at 2.42
3.9%
Planned (10b5-1)
2 Apr 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$24.53K 10,000 at 2.45
3.8%
Planned (10b5-1)
31 Mar 2026
Buonanno Franck Jean Vice-President, Global Sales
Sold on a plan
$23.50K 10,000 at 2.35
50.0%
Sold half or more
25 Mar 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$29.25K 10,000 at 2.92
5.7%
Planned (10b5-1)
24 Mar 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$29.00K 10,000 at 2.90
5.4%
Planned (10b5-1)
23 Mar 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$29.89K 10,000 at 2.99
5.1%
Planned (10b5-1)
20 Mar 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$29.99K 10,000 at 3.00
4.9%
Planned (10b5-1)
19 Mar 2026
O'Hara John Charles Chief Financial Officer
Sold on a plan
$30.19K 10,000 at 3.02
4.6%
Planned (10b5-1)
18 Mar 2026
Verjus Nathalie Claude Odile Company Secretary
Sold on a plan
$15.13K 5,000 at 3.03
2.6%
Planned (10b5-1)
Showing 1–38 of 38.